Walder Wyss acted as legal counsel to Alentis Therapeutics on the USD 67 million series B financing round. Morningside Venture Investments led the financing, joined by Jeito Capital and Series A investors Biomed Partners, BB Pureos Bioventures, Bpifrance through its InnoBio 2 fund, High-Tech Gründerfonds and Schroders Capital. Proceeds from the financing will be used […]
Faveeo, a Swiss start-up operating an AI-driven trusted content platform, announced the successful closing of its Series B financing round. The investment was led by a private equity fund and various business angels. No financial
UBS Group completed its issuance of USD 750 m 3.875 per cent Tier 1 Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill UBS Group’s Swiss going concern requirements. The Notes
Froriep acted as legal counsel for Iconic Funds in the launch of its Iconic Funds Physical Bitcoin ETP at SIX, effective May 28, 2021. In particular, the law firm advised Iconic Funds on the entire listing process.
With the advise of Homburger, Credit Suisse launched on May 17, 2021 and successfully completed on May 21, 2021, its issuance of (i) EUR 1.5 bn aggregate principal amount of 0.250% fixed rate senior notes due January 2026, and (ii) GBP 750 m
Bär & Karrer acted as legal advisors to CVC on its contribution to the funding received by Acronis, the global operator in cyber protection, for more than 250 million USD. Acronis received the funding from
Homburger is acting as legal advisor for Siegfried Holding in the placement of a CHF 200 million 0.20% Senior Bond due 2026. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The closing
Borel & Barbey acted as legal advisors for Alpian on the structuring and execution of its Series B fundraising of around CHF 17 million. On this transaction Borel & Barbey team was led by Luca Bozzo (
Borel & Barbey acted as legal advisors for Swissroc Investment on the acquisition of an industrial and logistics real estate portfolio of five properties in Switzerland. The transaction, totaling nearly 50 million CHF (including upcoming CAPEX),
Bratschi advised PHT International, as Swiss local counsel in the acquisition of all shares of PHT Pharmaceutical formerly known as BPh Investitionen. For this transaction, Bratschi team was led by Florian S. Jörg (pictured),
